Vaccine trial in SA fails to show efficacy in HIV prevention

Reading Time: < 1 minute

The Department of Health says it is disappointed that a large-scale HIV vaccine trial in South Africa failed to show efficacy in preventing HIV infection.

The HVTN 702 trial was the largest and most advanced HIV vaccine trial to take place in South Africa, a country with the largest HIV epidemic in the world.

The trial has now been stopped.

“This trial reinforces the fact that we must continue to look for a vaccine to prevent new infections. While researchers are searching for a vaccine we must do everything we can to prevent new infections, which means condomising, using pre-exposure prophylaxis, sticking to one partner at a time, etc. We look forward to the results of the other two trials that are currently taking place in SA,” says the Health Department’s Deputy Director-General for HIV/AIDS, Doctor Yogan Pillay.